Nano-engineered pomegranate oil holds hope for brain disease, study shows

A Israeli study has found that multiple sclerosis patients taking a nano-engineered nutritional supplement made out of pomegranate oil showed “significant cognitive improvement” after just three months.

The small-scale study of 30 patients was conducted at the Multiple Sclerosis Center at Hadassah Ein Kerem Hospital in Jerusalem by Prof. Dimitrios Karussis, director of the center and a senior neurologist. Results showed that patients taking the supplement witnessed an average 12 percent improvement in learning ability and text comprehension, word recall and categorization, in the three months of treatment.

The researchers are now writing up the findings to submit them to neurological journals for peer review, Karussis said in a phone interview.

The pomegranate oil supplement the patients were given was developed by Prof. Ruth Gabizon, a researcher of degenerative brain diseases at the Neurology Department of Hadassah University Hospital in Jerusalem, together with Prof. Shlomo Magdassi, an expert in the field of nanotechnology from the Casali Institute for Applied Chemistry at the Hebrew University.

Read the source entire article at The Times of Israel